<DOC>
	<DOCNO>NCT02718261</DOCNO>
	<brief_summary>Data show episodes bleeding may often observe critically ill patient dialysis-dependent acute renal failure ( ARF ) renal replacement therapy ( RRT ) . From clinical perspective , patient dialysis-dependent ARF end-stage renal disease ( ESRD ) may consider high risk population regard e.g . development gastrointestinal ( GI- ) bleeding . In current prospective subanalysis `` SIREN '' randomize placebo-controlled clinical trial `` SUP-ICU '' ( NCT02467621 ) , investigator seek elucidate whether subpopulation critically ill patient dialysis-dependent acute renal failure benefit prophylactic treatment proton-pump-inhibitor pantoprazole .</brief_summary>
	<brief_title>Sup-Icu RENal ( SIREN )</brief_title>
	<detailed_description />
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<criteria>please refer SUPICU ( NCT02467621 ) trial please refer SUPICU ( NCT02467621 ) trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>